Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...

Our Cipla Health franchise grew by 16% with margins reaching closer to mid-teens for the quarter. Big brands of Cipla Health scaled further by posting double-digit growth in revenues,” it stated.

NEW YORK, May 27, 2025 /PRNewswire/ -- Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG FORCE Walk, reaffirming its ...

Cipla's complex respiratory portfolio drives profitability, according to Sharekhan Anticipated rise in EBITDA margins to 26% by FY26E Stock trading at a revised PT of Rs. 1,700, up from Rs. 1,600 ...

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of its respiratory and cancer drugs in its key ...

NEW YORK, May 27, 2025 /PRNewswire/ -- Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG FORCE Walk, reaffirming its ...